SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 11-K
ANNUAL REPORT
PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
(Mark One:) |
|
|
ý |
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) |
|
|
|
|
For the fiscal year ended December 31, 2002 |
|
|
|
|
|
OR |
|
|
|
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) |
For the transition period from to
Commission file number: 000-21326
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
Anika Therapeutics, Inc.
401(K) Plan
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
Anika Therapeutics, Inc.
160 New Boston Street
Woburn, MA 01801
(781) 932-6616
REQUIRED INFORMATION
Item 4. Plan financial statements and schedule for the year ended December 31, 2002 have been prepared in accordance with the financial reporting requirements of ERISA.
|
Statements of Net Assets Available for Benefits as of December 31, 2002 and 2001 |
|
|
|
Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2002 |
Signature
The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees have duly caused this annual report to be signed on their behalf by the undersigned hereunto duly authorized.
|
|
Anika Therapeutics, Inc. |
||
|
|
Employee Savings and Retirement Plan |
||
|
|
|
||
|
|
|
By: /s/ William J. Knight |
|
|
|
|
William J. Knight, Trustee |
|
|
|
|
||
|
|
|
||
|
|
|
||
|
Dated: June 27, 2003 |
|
||
2
ANIKA THERAPEUTICS, INC.
EMPLOYEE SAVINGS & RETIREMENT PLAN
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
AS OF DECEMBER 31, 2002 and 2001
|
|
|
2002 |
|
2001 |
|
||
|
INVESTMENTS |
|
|
|
|
|
||
|
Participant directed, at fair value - |
|
|
|
|
|
||
|
Money market fund |
|
$ |
411,032 |
|
$ |
297,788 |
|
|
Employer common stock |
|
79,276 |
|
68,422 |
|
||
|
Mutual funds |
|
1,073,958 |
|
1,229,504 |
|
||
|
Participant loans |
|
32,265 |
|
84,839 |
|
||
|
Total investments |
|
1,596,531 |
|
1,680,553 |
|
||
|
|
|
|
|
|
|
||
|
CONTRIBUTIONS RECEIVABLE |
|
12,389 |
|
22,396 |
|
||
|
|
|
|
|
|
|
||
|
NET ASSETS AVAILABLE FOR BENEFITS |
|
$ |
1,608,920 |
|
$ |
1,702,949 |
|
F-1
Anika Therapeutics, Inc.
Employee Savings & Retirement Plan
STATEMENT OF CHANGES IN NET ASSETS AVAILABLE
FOR BENEFITS
FOR THE YEAR ENDED DECEMBER 31, 2002
|
|
|
2002 |
|
|
|
|
|
|
|
|
|
Interest & dividends |
|
$ |
25,020 |
|
|
|
|
|
|
|
|
Contributions by: |
|
|
|
|
|
Employees |
|
246,423 |
|
|
|
Employer |
|
150,109 |
|
|
|
Rollover distributions, net |
|
(17,151 |
) |
|
|
Total contributions |
|
379,381 |
|
|
|
|
|
|
|
|
|
Total additions |
|
404,401 |
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
Distributions to former participants |
|
210,941 |
|
|
|
Net increase (decrease) before realized gains(losses) |
|
193,460 |
|
|
|
|
|
|
|
|
|
Net realized and unrealized investment gains(losses) |
|
(287,489 |
) |
|
|
Net decrease in net assets |
|
(94,029 |
) |
|
|
Net assets available for benefits, beginning of year |
|
1,702,949 |
|
|
|
Net assets available for benefits, end of year |
|
$ |
1,608,920 |
|
F-2